Recombinant HIV1 + HIV2 envelope antigen protein

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The HIV1 and HIV2 envelope antigen also known as Env protein plays a central mechanical role in the HIV infection process. This protein exists as a trimeric spike on the viral surface facilitating the virus's ability to enter a host cell. The envelope antigen approximately 160 kDa comprises two subunits: gp120 and gp41 working together for host cell receptor binding and membrane fusion. Expression occurs on the surface of the HIV1 and HIV2 viruses where it interacts directly with the host immune system.

Biological function summary

The envelope antigen triggers immune response by presenting itself as a target for antibodies and T cells. Env protein forms part of a larger viral membrane complex critical in maintaining structural integrity and functional virulence of the virus. It engages with CD4 receptors and coreceptors on host cells like CCR5 or CXCR4 determining cell tropism and influencing viral pathogenesis in the immune system. Its presence significantly impacts the progression and severity of HIV infection.

Pathways

The envelope antigen is pivotal in the viral entry and fusion pathways. These pathways contribute key roles in the life cycle of both HIV1 and HIV2. Interaction of gp120 with its CD4 receptor and coreceptors facilitates the conformational changes necessary for gp41-mediated membrane fusion. This interaction is deeply intertwined with normal immune signalling pathways making it closely associated with human proteins like chemokine receptors such as CCR5 which are co-receptors.

The envelope antigen's presence is closely related to the pathophysiology of HIV/AIDS. Its variability and ability to escape immune detection are central challenges in vaccine development and treatment strategies for the disease. Additionally mutations in the Env protein correlate with drug resistance in treatments presenting further complications in disease management. The envelope glycoprotein's interactions with host proteins such as CD4 and CCR5 or CXCR4 highlight its role in not just HIV infection but potential susceptibilities to co-infections and related immune disorders.